Anti-tumor activities and apoptotic mechanism of ribosome-inactivating proteins

被引：29
作者：
Zeng, Meiqi [1 ]
Zheng, Manyin [1 ]
Lu, Desheng [1 ]
Wang, Jun [1 ]
Jiang, Wenqi [1 ,2 ,3 ,4 ]
Sha, Ou [1 ]
机构：
[1] Shenzhen Univ, Hlth Sci Ctr, Sch Med, Shenzhen 518060, Guangdong, Peoples R China
[2] Shenzhen Univ, Sch Med, Shenzhen 518060, Guangdong, Peoples R China
[3] State Key Lab Oncol South China, Guangzhou 510060, Guangdong, Peoples R China
[4] Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Guangdong, Peoples R China
来源：
CHINESE JOURNAL OF CANCER | 2015年 / 34卷
关键词：
Ribosome-inactivating protein (RIP); Anti-tumor; Apoptosis; Cancer; CELLS IN-VITRO; NASOPHARYNGEAL CARCINOMA-CELLS; ACUTE LYMPHOBLASTIC-LEUKEMIA; RGEL/BLYS FUSION TOXIN; CANCER-CELLS; ALPHA-SARCIN; ASPERGILLUS-GIGANTEUS; ANTI-CD33; IMMUNOTOXIN; ANTICANCER ACTIVITY; SIGNALING PATHWAY;
D O I：
10.1186/s40880-015-0030-x
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Ribosome-inactivating proteins (RIPs) belong to a family of enzymes that attack eukaryotic ribosomes and potently inhibit cellular protein synthesis. RIPs possess several biomedical properties, including anti-viral and anti-tumor activities. Multiple RIPs are known to inhibit tumor cell proliferation through inducing apoptosis in a variety of cancers, such as breast cancer, leukemia/lymphoma, and hepatoma. This review focuses on the anti-tumor activities of RIPs and their apoptotic effects through three closely related pathways: mitochondrial, death receptor, and endoplasmic reticulum pathways.
引用
收藏
页数：10
相关论文
共 50 条
  • [1] Anti-tumor activities and apoptotic mechanism of ribosome-inactivating proteins
    Meiqi Zeng
    Manyin Zheng
    Desheng Lu
    Jun Wang
    Wenqi Jiang
    Ou Sha
    Chinese Journal of Cancer, 2015, 34 (08) : 325 - 334
  • [2] Ribosome-inactivating proteins
    Stirpe, F
    TOXICON, 2004, 44 (04) : 371 - 383
  • [3] Ribosome-inactivating proteins: progress and problems
    F. Stirpe
    M. G. Battelli
    Cellular and Molecular Life Sciences CMLS, 2006, 63 : 1850 - 1866
  • [4] Ribosome-inactivating proteins: progress and problems
    Stirpe, F.
    Battelli, M. G.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2006, 63 (16) : 1850 - 1866
  • [5] Antiviral Activity of Ribosome-Inactivating Proteins
    Citores, Lucia
    Iglesias, Rosario
    Ferreras, Jose M.
    TOXINS, 2021, 13 (02)
  • [6] Anti-tumor action of trichosanthin, a type 1 ribosome-inactivating protein, employed in traditional Chinese medicine: a mini review
    Ou Sha
    Junfei Niu
    Tzi-Bun Ng
    Eric Yu-Pang Cho
    Xiaoyuan Fu
    Wenqi Jiang
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 1387 - 1393
  • [7] Immunotoxins Constructed with Ribosome-Inactivating Proteins and their Enhancers: A Lethal Cocktail with Tumor Specific Efficacy
    Gilabert-Oriol, Roger
    Weng, Alexander
    von Mallinckrodt, Benedicta
    Melzig, Matthias F.
    Fuchs, Hendrik
    Thakur, Mayank
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (42) : 6584 - 6643
  • [8] Anti-tumor action of trichosanthin, a type 1 ribosome-inactivating protein, employed in traditional Chinese medicine: a mini review
    Sha, Ou
    Niu, Junfei
    Ng, Tzi-Bun
    Cho, Eric Yu-Pang
    Fu, Xiaoyuan
    Jiang, Wenqi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (06) : 1387 - 1393
  • [9] Comparison of ribosome-inactivating proteins in the induction of apoptosis
    Williams, JM
    Lea, N
    Lord, JM
    Roberts, LM
    Milford, DV
    Taylor, CM
    TOXICOLOGY LETTERS, 1997, 91 (02) : 121 - 127
  • [10] Suicide nanoplasmids coding for ribosome-inactivating proteins
    Mitdank, Hardy
    Troeger, Meike
    Sonntag, Alexander
    Shirazi, Nima Amini
    Woith, Eric
    Fuchs, Hendrik
    Kobelt, Dennis
    Walther, Wolfgang
    Weng, Alexander
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 170
12345